Autologous stem cell transplantation using MEAM regimen for relapsed AIDS-related lymphoma patients who received highly active anti-retroviral therapy: A report of three cases

Internal Medicine

Volumn 48, Issue 2, 2009, Pages 111-114

  Kawabata, Kimihito C ^a   Hagiwara, Shotaro ^a   Takenouchi, Ayako ^a   Tanimura, Akira ^a   Tanuma, Junko ^a   Tachikawa, Natsuo ^a   Miwa, Akiyoshi ^a   Oka, Shinichi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

AIDS; HIV; Lymphoma; MCNU; Stem cell transplantation

Indexed keywords

ANTIRETROVIRUS AGENT; ATAZANAVIR; CARBOPLATIN; CD20 ANTIGEN; CD4 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LAMIVUDINE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; NELFINAVIR; PREDNISOLONE; PREDNISONE; RANIMUSTINE; RITONAVIR; RITUXIMAB; STAVUDINE; TENOFOVIR DISOPROXIL; VINCRISTINE; ANTINEOPLASTIC AGENT; NITROSOUREA DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANOREXIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; BRAIN LYMPHOMA; BREAST TUMOR; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CHEMOTHERAPY INDUCED EMESIS; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG TOLERABILITY; ENDOSCOPIC BIOPSY; FACIAL NERVE PARALYSIS; FEBRILE NEUTROPENIA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LARGE CELL LYMPHOMA; LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SEROLOGY; STOMATITIS; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; RECURRENT DISEASE; SALVAGE THERAPY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYTARABINE; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MELPHALAN; NITROSOUREA COMPOUNDS; RECURRENCE; SALVAGE THERAPY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 61749084027     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1295     Document Type: Article

References (15)

1. Cote TR, Biggar RJ, Rosenberg PS, et al. Non-Hodkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/ Cancer Study Group. Int J Cancer 73: 645-650, 1997.
2. Raphael M, Borisch B, Jalle ES. Lymphoma associated with infection by the human immune deficiency virus (HIV). In: WHO Classification of Tumours, Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues. Elaine S, Harris LN, Stein H, Vardiman JW, Eds. IARC Press, Lyon, 2001: 260-263.
3. Little RF, Pittaluga S, Grant N, et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 101: 4653-4659, 2003.
4. Boue F, Gabarre J, Gisselbrecht C, et al. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. J Clin Oncol 24: 4123-4128, 2006.
5. Spina M, Jaeger U, Sparano JA, et al. Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin's lymphoma: pooled results from 3 phase 2 trials. Blood 105: 1891-1897, 2005.
6. Gabarre J, Azar N, Autran B, Katlama C, Leblond V. High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet 355: 1071-1072, 2000.
7. Krishnan A, Molina A, Zaia J, et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 105: 874-878, 2005.
8. Balsalobre P, Diez-Martin JL, Re A, et al. Autologous stem cell transplantation in HIV associated lymphoma patients: An updated analysis of the EBMT lymphoma working party experience. Blood 110: abstract #1887, 2007.
9. Spitzer TR, Ambinder RF, Lee JY, et al. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium Study 020. Biol Blood Marrow Transplant 14: 59-66, 2008.
10. Kawano Y, Takaue Y, Miyama J, et al. Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. Blood 92: 4040-4046, 1998.
11. Ishii R, Morimoto A, Hibi S, Sugimoto T, Imashuku S. Successful treatment with autologous peripheral blood stem cell transplantation for a relapsed Hodgkin's disease with lung infiltration. Jpn J Pediatr Hematol 19: 25-29, 2005 (in Japanese).
12. Hodozuka A, Sako K, Nakai H, Tomabechi M, Suzuki N, Yonemasu Y. Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus intravenous infusion. J Neurooncol 15: 79-86, 1993.
13. Mills W, Chopra R, McMillan A, Pearce R, Linch DC, Goldstone AH. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol 13: 588-595, 1995.
14. Serrano D, Carrion R, Balsalobre P, et al. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol 33: 487-494, 2005.
15. Re A, Cattaneo C, Michieli M, et al. High-dose therapy and autologous peripheral blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 21: 4423-4427, 2003.